Tatt Jhong Haw

Dr. Tatt Jhong Haw is a Postdoctoral Research Fellow at the University of Newcastle's School of Medicine and Public Health and Hunter Medical Research Institute (HMRI). As a member of the International Cardio-Oncology Society-certified Newcastle Cardio-Oncology Research Program, he specializes in developing human induced-pluripotent stem cell-derived cardiomyocyte models for individualized cardiovascular risk assessment in cancer patients. He also leads multidisciplinary research on environmental cardiopulmonary impacts in regional Australia, focusing on bushfire smoke and coal dust exposure.

• Doctor of Philosophy, University of Newcastle
• Bachelor of Science (Honours) in Biomedical Science, International Medical University, Malaysia

His research bridges cardio-oncology and environmental health, addressing chemotherapy-induced cardiotoxicity (e.g., doxorubicin, carfilzomib) and airborne pollutant effects on respiratory-cardiac function. He pioneered models for bushfire smoke exposure and developed therapeutic strategies for COPD and steroid-insensitive asthma via miRNA-21/PI3K pathway modulation.

Key publication trends include:

• Shared mechanisms between cancer therapies and cardiotoxic effects
• Environmental pollutant impacts on cardiopulmonary systems
• Epigenetic and molecular pathway analyses in respiratory diseases
• Microbiome-COPD interactions
• TLR signaling in smoke-induced pathologies

Scientific recognitions include

• 2021 Heart Foundation Vanguard Grant ($75,000)
• 2022 MRFF Cardiovascular Health Mission Grant ($999,998)
• 2018 TSANZ Boehringer Ingelheim COPD Research Award ($30,000)
• Multiple travel grants from HMRI and Cardiovascular Research Network

Haw has secured over $1.2 million in competitive funding across 8 grants, including 3 Category 1 grants. He has co-authored 31 journal articles (H-index 15, >1,150 citations) and led >12 industry projects testing respiratory therapeutics. His work involves collaborations with Professors Aaron Sverdlov, Doan Ngo, and Jay Horvat, as well as multidisciplinary teams across HMRI and University of Newcastle.